DeepCure
PrivateLast Round
Series A
Extension
Apr 11, 2024
Total Funding Raised
$31.6M
Company Overview
DeepCure operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series A Extension round in April 2024.
DeepCure is a biotechnology company that develops novel small molecule therapeutics for immune and inflammatory diseases using an AI-driven drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DeepCure Comparables
Compare DeepCure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PostEra | 89% | |
| Superluminal Medicines | 86% | |
| Valo Health | 84% |
For institutional investors. Book with your work email.
DeepCure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Apr 11, 2024 | ||||
| Seed | Nov 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DeepCure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IAG Capital Partners | Series A Extension |
| Morningside Ventures | Series A Extension, Seed |
| TLV Partners | Series A Extension, Seed |
| Benon Group | Series A Extension, Seed |
| The E14 Fund | Series A Extension, Seed |
| Sapir Venture Partners | Series A Extension, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2021
$7M round led by Morningside Ventures
For institutional investors. Book with your work email.
DeepCure Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DeepCure's valuation, stock price, and market status.
Is DeepCure a public or private company?
DeepCure is a private company.
What is the current stock price of DeepCure?
DeepCure is a private company, so its shares have no public market price. Caplight tracks DeepCure's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DeepCure worth (valuation)?
Valuation information for DeepCure is not publicly available.
Can I buy DeepCure stock?
DeepCure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DeepCure's last funding round?
DeepCure's most recent funding round was Series A Extension on April 11, 2024.
Who are the main investors in DeepCure?
Key investors in DeepCure include IAG Capital Partners, Morningside Ventures.
Will DeepCure IPO soon?
No public IPO plans have been announced for DeepCure.
How can I track DeepCure secondary market activity?
Caplight tracks bids, offers, and trades in DeepCure's shares on secondary markets.